Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab

Kum C. Fok, Watson W. S. Ng, Christopher J. A. Henderson, Susan J. Connor

    Research output: Contribution to journalArticlepeer-review

    28 Citations (Scopus)

    Abstract

    The advance of anti-tumour necrosis factor (TNF) therapy had dramatically changed the treatment algorithm of inflammatory bowel disease (IBD). This had significantly improved the quality of life for patients with Crohn's disease (CD) and ulcerative colitis (UC). However, side-effects of anti-TNF treatment were unavoidable with paradoxical inflammation (for example leucocytoclastic vasculitis and psoriasis) being well-known phenomena of anti-TNF therapy. We report a case of infliximab induced cutaneous sarcoidosis in a patient with ulcerative colitis and review the literature.
    Original languageEnglish
    Pages (from-to)708-712
    Number of pages5
    JournalJournal of Crohn's and Colitis
    Volume6
    Issue number6
    DOIs
    Publication statusPublished - 2012

    Keywords

    • alanine aminotransferase
    • infliximab
    • sarcoidosis
    • side, effects
    • ulcerative colitis

    Fingerprint

    Dive into the research topics of 'Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab'. Together they form a unique fingerprint.

    Cite this